|
Lipodystrophy defined clinically
|
defined by FMR
|
|---|
| |
Total
|
Without CL
|
With CL
|
P
|
Without L
|
With L
|
P
|
|---|
|
HOMA-IR [median (IQR)]
|
1.9 (2.8)
|
1.7 (2.4)
|
2.1 (3.0)
|
0.229
|
1.6 (2.6)
|
2.8 (2.8)
|
<0.001
|
|
HOMA-B [median (IQR)]
|
92.3 (106.4)
|
92.3 (91.1)
|
91.8 (117.5)
|
0.855
|
92.3 (96.1)
|
85.4 (120.8)
|
0.633
|
|
QUICKI [median (IQR)]
|
0.34 (0.06)
|
0.35 (0.06)
|
0.34 (0.06)
|
0.229
|
0.36 (0.07)
|
0.33 (0.05)
|
<0.001
|
|
MATSUDA [median (IQR)]
|
4.8 (5.1)
|
5.0 (4.2)
|
4.7 (5.4)
|
0.735
|
5.9 (5.3)
|
4.1 (4.4)
|
0.002
|
|
Glucose [mg/dL, median (IQR)]
|
93.5 (26.0)
|
90.0 (23.0)
|
97.0 (35.5)
|
0.046
|
90.0 (23.0)
|
97.0 (35.5)
|
0.002
|
|
Insulin [μU/mL, median (IQR)]
|
8.1 (9.6)
|
7.9 (8.2)
|
9.0 (10.2)
|
0.365
|
7.5 (8.1)
|
10.1 (9.9)
|
0.003
|
|
A1c [% median (IQR)]
|
5.3 (0.7)
|
5.2 (0.6)
|
5.3 (0.9)
|
0.091
|
5.2 (0.6)
|
5.5 (0.9)
|
0.002
|
- (CL- clinical lipodystrophy; L- lipodystrophy).
